CEVCP | China-EU Vaccine Industry Collaboration Platform

Product

Service

Project

Request

[BO-project] A Chinese innovative biotech company looks for partners for development of the next generation OMV-based bacterial vaccines

Project No :BO-CN-20231103-005

Summary

A Chinese innovative biotech company looks for partners for development of the next generation OMV-based bacterial vaccines

Project description

An innovative biotech company from Shanghai, Founded in 2021, utilizes synthetic biology tools and innovative mechanisms of action to create next-generation genetically engineered bacterial vaccines. With two technology platforms and over six pipelines, this company presents a promising solution to address global vaccine challenges, specifically the problem of antimicrobial resistance (AMR). This company raised $14M seed financing and is seeking for collaborations and license-out opportunities on multiple pipelines.

This company has established genetically modified OMV vaccine platform to enable the development of the next generation OMV-based bacterial vaccines. Our OMV platform enables the co-delivery of proteins and polysaccharide without the need of adjuvant. Currently they are welcome to explore potential collaborations in developing various OMV-based bacterial vaccines, including OMV-based pertussis vaccine, OMV-based TB vaccine, OMV-based K. pneumoniae vaccine and more.

Stage:

Laboratory tested

Contact

Erika HAN

Tel: 086-028-85335757

Email: Erika_han@eupic.cn

Expression of Interest

submit

Already have an account? Log in

By registered, you agree to the Conference Registration Privacy Policy.

Conference Registration Privacy Policy

I. Introduction

We highly value and respect the privacy rights and information security of our participants. When you register for our conference activities, we promise to properly handle and protect your personal information in accordance with this Privacy Policy. Please read this Privacy Policy carefully before registration to ensure that you fully understand and agree with our privacy protection measures.

II. Information Collection

We will collect the personal information you provide during the registration process, including but not limited to your name, contact details, email address, work unit, etc.
We may collect your feedback opinions, behavioral data, etc., through your participation in conference activities, questionnaires, interactive sessions, and other methods.
We will use the personal information you provide to contact you, confirm registration details, send conference notifications, provide conference-related materials, etc.
We will use your feedback opinions and behavioral data to optimize conference arrangements and improve service quality.
Without your explicit consent, we will not use your personal information for other purposes, nor will we sell or provide your personal information to third parties.

Agree